The stock of HCA Healthcare Inc (HCA) has gone down by -12.51% for the week, with a -9.98% drop in the past month and a 1.34% rise in the past quarter. The volatility ratio for the week is 2.30%, and the volatility levels for the past 30 days are 2.35% for HCA. The simple moving average for the past 20 days is -8.55% for HCA’s stock, with a 6.70% simple moving average for the past 200 days.
Is It Worth Investing in HCA Healthcare Inc (NYSE: HCA) Right Now?
HCA Healthcare Inc (NYSE: HCA) has a higher price-to-earnings ratio of 16.32x compared to its average ratio. HCA has 36-month beta value of 1.67. Analysts have mixed views on the stock, with 10 analysts rating it as a “buy,” 6 as “overweight,” 6 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for HCA is 185.65M, and currently, short sellers hold a 1.54% ratio of that float. The average trading volume of HCA on October 28, 2024 was 1.12M shares.
HCA) stock’s latest price update
HCA Healthcare Inc (NYSE: HCA)’s stock price has decreased by -8.86 compared to its previous closing price of 398.90. However, the company has seen a -12.51% decrease in its stock price over the last five trading sessions. investopedia.com reported 2024-10-25 that Major U.S. equities indexes were mixed on the final day of trading in a week dominated by a steady flow of earnings reports as well as increasing questions about how quickly the Federal Reserve will proceed with interest-rate reductions.
Analysts’ Opinion of HCA
Many brokerage firms have already submitted their reports for HCA stocks, with KeyBanc Capital Markets repeating the rating for HCA by listing it as a “Overweight.” The predicted price for HCA in the upcoming period, according to KeyBanc Capital Markets is $475 based on the research report published on October 11, 2024 of the current year 2024.
Morgan Stanley, on the other hand, stated in their research note that they expect to see HCA reach a price target of $427. The rating they have provided for HCA stocks is “Equal-Weight” according to the report published on September 03rd, 2024.
Robert W. Baird gave a rating of “Outperform” to HCA, setting the target price at $396 in the report published on May 30th of the current year.
HCA Trading at -7.87% from the 50-Day Moving Average
After a stumble in the market that brought HCA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.85% of loss for the given period.
Volatility was left at 2.35%, however, over the last 30 days, the volatility rate increased by 2.30%, as shares sank -9.85% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.24% lower at present.
During the last 5 trading sessions, HCA fell by -12.51%, which changed the moving average for the period of 200-days by +28.69% in comparison to the 20-day moving average, which settled at $397.56. In addition, HCA Healthcare Inc saw 34.31% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HCA starting from Cuffe Michael S., who sale 8,358 shares at the price of $385.42 back on Sep 12 ’24. After this action, Cuffe Michael S. now owns 29,678 shares of HCA Healthcare Inc, valued at $3,221,340 using the latest closing price.
Cuffe Michael S., the Officer of HCA Healthcare Inc, proposed sale 8,358 shares at $385.42 during a trade that took place back on Sep 12 ’24, which means that Cuffe Michael S. is holding shares at $3,221,340 based on the most recent closing price.
Stock Fundamentals for HCA
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.11 for the gross margin
The net margin for HCA Healthcare Inc stands at 0.02. The total capital return value is set at 0.04.
Based on HCA Healthcare Inc (HCA), the company’s capital structure generated 0.54 points at debt to capital in total, while cash flow to debt ratio is standing at 0.24. The debt to equity ratio resting at 1.18. The interest coverage ratio of the stock is 1.38.
Currently, EBITDA for the company is 12.73 billion with net debt to EBITDA at 4.56. When we switch over and look at the enterprise to sales, we see a ratio of 1.95. The receivables turnover for the company is 7.02for trailing twelve months and the total asset turnover is 0.78. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.12.
Conclusion
To put it simply, HCA Healthcare Inc (HCA) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
